Custom Report

La Merie Publishing offers the service of preparing customized reports tailored to the needs and specifications of the customer. We conduct scientific & medical literature evaluations for clients of the biopharmaceutical industry within the scope of our expertise. Target or technology pipeline and corporate benchmark analysis and assessment reports can be prepared according to the specifications of the client from the pharmaceutical or biotechnology industry.

More info

CALGARY, Canada I December 4, 2020 I Providence Therapeutics confirmed today that a Clinical Trial Application (CTA) was submitted to Health Canada, December 3, for the mRNA COVID vaccine, PTX-COVID19-B. The company has been keeping Health Canada informed through development of the vaccine candidate.

The Company will not comment further until appropriate discussions have been concluded with Health Canada.

SOURCE: Providence Therapeutics

Post Views: 360